Drug Shortage Report for AXID
Report ID | 96674 |
Drug Identification Number | 00778338 |
Brand name | AXID |
Common or Proper name | Nizatidine Capsules USP |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | NIZATIDINE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 caps |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-10-16 |
Actual start date | 2019-10-16 |
Estimated end date | Unknown |
Actual end date | 2019-12-17 |
Shortage status | Resolved |
Updated date | 2019-12-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-10-16 | English | Compare |
v2 | 2019-10-16 | French | Compare |
v3 | 2019-10-17 | English | Compare |
v4 | 2019-11-29 | English | Compare |
v5 | 2019-11-29 | French | Compare |
v6 | 2019-12-18 | English | Compare |
v7 | 2019-12-18 | French | Compare |
Showing 1 to 7 of 7